Eliciting neutralizing antibodies with gp120 outer domain by Y Qin et al.
ORAL PRESENTATION Open Access
Eliciting neutralizing antibodies with gp120
outer domain
Y Qin1*, DP Han1, K Takamoto2, MW Cho1
From AIDS Vaccine 2012
Boston, MA, USA. 9-12 September 2012
Background
Although gp120 elicits strong antibody responses, it fails
to induce broadly neutralizing antibodies (bnAbs). One
strategy being evaluated is using immunogens based on
gp120 outer domain (gp120-OD). A number of gp120-
OD constructs have been reported. However, none of
them have been shown to induce potent nAbs. Here, we
describe gp120-OD-based immunogens that can induce
potent nAbs.
Methods
We constructed gp120, gp120-OD, and a trimeric form
of gp120-OD (ODx3) based on an M group consensus
sequence. Proteins were expressed in 293 cells, and their
antigenic properties were evaluated by immunoprecipi-
tation using gp120 bnAbs (b12, 2G12 and 447-52D) and
by surface plasmon resonance (SPR). Rabbits were
immunized and antibody responses were characterized
by ELISA and neutralization assays.
Results
All three proteins were recognized by bnAbs b12, 2G12
and 447-52D. SPR analyses indicated that b12 has lower
affinity to gp120-OD compared to gp120 or ODx3, lar-
gely due to a faster dissociation rate. All immunogens
induced potent nAbs against Tier 1 viruses from clades
B, C and AE. Neutralizing activity against Tier 2 viruses
was weaker and sporadic. The induction kinetic of nAbs
by gp120-OD was slower than that for gp120 and
ODx3. Although the V3 loop was a major target of
nAbs, results suggested other epitopes are also targeted.
A panel of about 100 rabbit mAbs was generated, two
of which exhibited neutralizing activity. One of them
was molecularly cloned and sequenced. It exhibited a
similar neutralization profile as the immune serum.
Work is in progress to identify its epitope.
Conclusion
We have successfully generated OD-based immunogens
that can induce nAbs. Although they were effective pri-
marily against Tier 1 viruses, the breadth of neutralizing
activity achieved is highly significant. Our trimeric ODx3
construct is novel and is a highly promising immunogen
for further development of OD-based immunogen.
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